Based on the above evidence, we propose that manipulation of the TDO–Kyn–AhR pathway by HCV has a pathogenic role in the HCV-infected liver through bystander suppression of anti-tumour immune responses, thus allowing the progression of HCV infection into HCC. Here, AHR is linked to neoplasm.